25P-NBOMe

25P-NBOMe is a derivative of the phenethylamine 2C-P. It acts in a similar manner to related compounds such as 25I-NBOMe, which are potent agonists at the 5-HT_2A receptor. 25P-NBOMe has been sold as a drug and produces similar effects in humans to related compounds such as 25I-NBOMe and 25C-NBOMe.

Use and effects

The dose range of 25P-NBOMe has been given as 0.1 to 1.5mg sublingually, with a typical dose estimate of 0.6mg.

Pharmacology

Pharmacodynamics

25P-NBOMe is a potent agonist of the serotonin 5-HT₂ receptors, including the serotonin 5-HT_2A receptor.

History

25P-NBOMe was first described in the scientific literature by 2012.

Society and culture

Legal status

Canada

25P-NBOMe is a controlled substance in Canada under phenethylamine blanket-ban language.